Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Home
Profiles
Research units
Research output
Prizes
Search by expertise, name or affiliation
Prevention of Anthracycline Cardiotoxicity by Iron Chelation
Chaim Hershko
*
, Arie Pinson
,
Gabriela Link
*
Corresponding author for this work
Department of Nutrition and Human Metabolism
Research output
:
Contribution to journal
›
Article
›
peer-review
41
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prevention of Anthracycline Cardiotoxicity by Iron Chelation'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anthracycline Toxicity
33%
Anthracycline-induced Cardiotoxicity
100%
Anthracyclines
100%
Antineoplastic Drugs
33%
Antitumoral Action
33%
Cardiolipin
33%
Cardioprotection
33%
Cell Organelles
33%
Cumulative Dose
33%
Deferoxamine
100%
Dose-dependent Toxicity
33%
Doxorubicin-induced Cardiotoxicity
33%
Free Radicals
33%
Haber-Weiss Reaction
33%
Inner Mitochondrial Membrane
33%
Iron Chelation
100%
Iron Depletion
33%
Iron Loading
33%
Mitochondria-associated Membranes
33%
Mitochondrial Damage
33%
Mitochondrial Respiratory Chain
33%
Oxidative Damage
33%
Phospholipid Component
33%
Polyunsaturated Fatty Acids
33%
Redox Cycling
33%
Pharmacology, Toxicology and Pharmaceutical Science
Anthracycline
100%
Anthracycline Toxicity
20%
Cardiolipin
20%
Cardiotoxicity
100%
Deferoxamine
60%
Doxorubicin
20%
Free Radical
20%
Iron
100%
Phospholipid
20%
Polyunsaturated Fatty Acid
20%